Toggle menu
  • Login or Sign Up
  • 0
    • GBP
      • British Pound
      • US Dollar
  • Biopharma Research
    Reset Search ×
    • 0
    Reset Search ×
    • GBP
      • British Pound
      • US Dollar

      Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    • GBP
      • British Pound
      • US Dollar
    • Gift Certificates
    • Login or Sign Up

    Market ReportsMarket Reports

    Shop by Category

  • All Diagnostics Markets
  • PARTNERING, LICENSING, M&A
  • Multiplex Diagnostics
  • Therapeutics
  • Genomics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • COVID-19 Diagnostics
  • Point of Care (POC) Diagnostics
  • Direct-to-Consumer (DTC) Diagnostics
  • Rapid Diagnostics
  • Laboratory Techniques
  • Medical Laboratory Services
  • Calibration

    • Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    Reset Search ×
    • 0
    • Home
    • Cancer Diagnostics
    • Cancer Molecular Diagnostics: Strategies and Trends, Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides 2023 to 2027
  • Cancer Molecular Diagnostics Markets 2023 to 2027
  • Cancer Molecular Diagnostics Markets 2023 to 2027

    Cancer Molecular Diagnostics: Strategies and Trends, Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides 2023 to 2027

    £5,647.06
    (You save )
    Write a Review

    SKU:
    HSR-106-SI
    Availability:
    Report will be sent upon receipt of cleared funds and confirmation of delivery email address.

    Adding to cart… category.add_cart_announcement

    Share This Article

    • Overview

    Product Description

    Cancer Molecular Diagnostics: Strategies and Trends, Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides 2023 to 2027

     

    “Companion Diagnostics and Liquid Biopsy drive market growth.  New cancer diagnostic segments emerging"

    Publication date: July 2023

    Page count: 419

    Table of Contents

    After a pandemic interruption the market for Cancer Molecular Diagnostics is back on the growth path, with growth accelerating in all segments. A range of dynamic trends are pushing market growth and company valuations, including:

    • Personalized medicine
    • Pharmacogenomics
    • Liquid biopsy
    • Minimal residual disease testing
    • Emergence of new economies with large markets
    • Physician diagnostics being displaced by new intelligent diagnostic tests

    Exciting technical developments especially in companion diagnostics (CDx), hold the promise of a dynamic, growing and evolving world market where single laboratories serve a global patient base.

    The report includes:

    • 120+ company profiles
    • Market forecasts 2023 to 2027 by cancer type
      • Breast
      • Colorectal
      • Lung
      • Prostate
      • Blood
      • Cervical
      • Melanoma
      • Companion Dx Development
      • Other
    • Market forecasts 2023 to 2027 by product
      • MDx instruments
      • MDx reagents
      • MDx software and services
    • Market forecasts 2023 to 2027 by place/setting
      • MDx clinical laboratory
      • MDx pharmaceutical
      • MDx research

    The report includes a complete list of Current United States Medicare Fee Payment Schedules to help understand test pricing in detail.

    ABOUT THE LEAD AUTHOR

    Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

    • B.Sc. (Chemistry) University of BC
    • M.B.A. (Finance and Policy) University of BC
    • Market Research Seminar - Burke Institute
    • Finance for Senior Executives - Harvard Business School

    Product Videos

    Custom Field

    Product Reviews

    Write a Review

    Write a Review

    ×
    Cancer Molecular Diagnostics Markets 2023 to 2027
    Cancer Molecular Diagnostics: Strategies and Trends, Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides 2023 to 2027
    ×
    • Recommended
    Cancer Immunotherapy Markets 2023 to 2027
    Quick view

    Cancer Immunotherapy Markets - The Race for the Cures: Forecasts for Immuno-Oncology Therapeutics by Cancer, Therapy and Customer with Executive and Consultant Guides 2023 to 2027

    £5,647.06 - £11,298.16
    Choose Options
    Immunoassay Markets 2023 to 2027
    Quick view

    Immunoassay Markets: Strategies and Trends, Forecasts by Application, Technology, Product, User and Country with Executive and Consultant Guides 2023 to 2027

    £5,647.06 - £11,298.16
    Choose Options
    Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2023 to 2027
    Quick view

    CLINICAL LABORATORY MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASE MARKETS: Strategies and Trends, Forecasts by Application and Country with Market Analysis & Executive Guides 2023 to 2027

    £5,647.06 - £11,298.16
    Choose Options
    Liquid Biopsy Markets 2023 to 2027 Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place and Product with Price and Volume Outlook with Executive and Consultant Guides 2023 to 2027
    Quick view

    Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place and Product with Price and Volume Outlook with Executive and Consultant Guides 2023 to 2027

    £5,647.06 - £11,298.16
    Choose Options
    Genomic Cancer Panel and Profiling Markets 2023 to 2027
    Quick view

    Genomic Cancer Panel and Profiling Markets by Cancer, Application, Tissue and Gene Type with Screening Potential Market Size and Executive/Consultant Guides 2023 to 2027

    £5,647.06 - £11,298.16
    Choose Options
    • Recommended
    • Cancer Immunotherapy Markets 2023 to 2027
      Quick view

      Cancer Immunotherapy Markets - The Race for the Cures: Forecasts for Immuno-Oncology Therapeutics by Cancer, Therapy and Customer with Executive and Consultant Guides 2023 to 2027

      £5,647.06 - £11,298.16
      Choose Options
    • Immunoassay Markets 2023 to 2027
      Quick view

      Immunoassay Markets: Strategies and Trends, Forecasts by Application, Technology, Product, User and Country with Executive and Consultant Guides 2023 to 2027

      £5,647.06 - £11,298.16
      Choose Options
    • Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2023 to 2027
      Quick view

      CLINICAL LABORATORY MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASE MARKETS: Strategies and Trends, Forecasts by Application and Country with Market Analysis & Executive Guides 2023 to 2027

      £5,647.06 - £11,298.16
      Choose Options
    • Liquid Biopsy Markets 2023 to 2027 Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place and Product with Price and Volume Outlook with Executive and Consultant Guides 2023 to 2027
      Quick view

      Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place and Product with Price and Volume Outlook with Executive and Consultant Guides 2023 to 2027

      £5,647.06 - £11,298.16
      Choose Options
    • Genomic Cancer Panel and Profiling Markets 2023 to 2027
      Quick view

      Genomic Cancer Panel and Profiling Markets by Cancer, Application, Tissue and Gene Type with Screening Potential Market Size and Executive/Consultant Guides 2023 to 2027

      £5,647.06 - £11,298.16
      Choose Options
    ×
    Contact Us
    Westfield House
    Millfield Lane
    Nether Poppleton
    YORK, YO26 6GA
    United Kingdom
    +44(0)1904 868857
    Accounts & Orders
    • Login or Sign Up
    • Order Status
    • Privacy Security Shipping
    Navigate
    • OUR SERVICES
    • ABOUT US
    • CONTACT US
    Join Our Mailing List

    Sign up for our newsletter to receive specials and up to date product news and releases.

    • © Biopharma Research Ltd